Nine doses of Sabin-type polio vaccine, London, England, 1994
In 1957, Albert Bruce Sabin (1906-93), a Russian-American bacteriologist, developed the polio vaccine that carries his name. Each plastic tube contains a dose of Sabin-type polio vaccine, which is to be administered orally. The Sabin-type vaccine largely replaced the earlier injectable vaccine developed by Sabin’s rival, Jonas Salk. This particular vaccine was manufactured by The Wellcome Foundation Ltd and supplied by Evans Medical Ltd.
Related Themes and Topics
An infectious disease affecting the central nervous system. Affected individuals can exhibit a range of symptoms if the polio virus enters the blood stream.
A substance given to humans or animals to improve immunity from disease. A vaccine can sometimes contain a small amount of bacteria that is designed to stimulate the body's reaction to that particular disease. The first vaccine was developed in 1796 by Edward Jenner to prevent smallpox.